First Manhattan’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,600
Closed -$124K 695
2024
Q2
$124K Hold
10,600
﹤0.01% 644
2024
Q1
$223K Hold
10,600
﹤0.01% 636
2023
Q4
$190K Sell
10,600
-573,030
-98% -$10.1M ﹤0.01% 652
2023
Q3
$9.61M Buy
583,630
+34,500
+6% +$625K 0.04% 147
2023
Q2
$11M Buy
549,130
+101,400
+23% +$1.95M 0.04% 128
2023
Q1
$8.47M Buy
447,730
+10,600
+2% +$235K 0.03% 157
2022
Q4
$9.91M Sell
437,130
-268,600
-38% -$6.07M 0.04% 152
2022
Q3
$18.7M Hold
705,730
0.08% 101
2022
Q2
$17.4M Buy
705,730
+9,365
+1% +$234K 0.07% 110
2022
Q1
$23.1M Buy
696,365
+105,305
+18% +$2.93M 0.08% 105
2021
Q4
$19.3M Buy
591,060
+22,792
+4% +$776K 0.06% 119
2021
Q3
$23.8M Buy
568,268
+174,700
+44% +$6.29M 0.09% 100
2021
Q2
$15.3M Buy
393,568
+60,178
+18% +$2.15M 0.06% 132
2021
Q1
$11.4M Sell
333,390
-25,800
-7% -$1.1M 0.05% 147
2020
Q4
$16.3M Buy
359,190
+259,847
+262% +$9.08M 0.08% 118
2020
Q3
$2.73M Buy
99,343
+12,835
+15% +$418K 0.01% 268
2020
Q2
$3.19M Sell
86,508
-1,700
-2% -$63.4K 0.02% 256
2020
Q1
$2.86M Buy
+88,208
New +$3.68M 0.02% 264

Other funds holding RGNX